Paladin Labs Stock Price, News & Analysis (TSE:PLB)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Paladin Labs (TSE:PLB)

Paladin Labs logoPaladin Labs Inc. is a specialty pharmaceutical company focused on developing, acquiring, in-licensing, marketing and distributing pharmaceutical products. The Company's product portfolio includes Tridural, Abstral and Trelstar. Tridural is a once-a-day tramadol product indicated as a first-line therapy for adults with moderate pain requiring several days or more of treatment. Abstral is a sublingual tablet used for the management of breakthrough cancer pain in patients who are already tolerant to other opioid analgesics. Trelstar is an injectable, luteinizing hormone releasing hormone agonist indicated for the palliative treatment of prostate cancer and endometriosis. In July 2013, the Company became the sole holder of Allon Therapeutics Inc. In September 2013, Blackstar Group SE announced that it has sold remaining 13.4% interests in Litha Healthcare Group Limited (Litha) to Paladin Labs Inc. Effective January 1, 2014, Paladin Labs Inc. acquired Triton Pharma Inc.

Receive PLB News and Ratings via Email

Sign-up to receive the latest news and ratings for PLB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolTSE:PLB
CUSIPN/A
Phone+1-514-3401112

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

Paladin Labs (TSE:PLB) Frequently Asked Questions

What is Paladin Labs' stock symbol?

Paladin Labs trades on the Toronto Stock Exchange (TSX) under the ticker symbol "PLB."

Who are some of Paladin Labs' key competitors?

How do I buy Paladin Labs stock?

Shares of Paladin Labs and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

How can I contact Paladin Labs?

Paladin Labs' mailing address is 100 Alexis-Nihon Blvd Suite 600, SAINT-LAURENT, QC H4M 2P2, Canada. The specialty pharmaceutical company can be reached via phone at +1-514-3401112.


MarketBeat Community Rating for Paladin Labs (PLB)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  42 (Vote Outperform)
Underperform Votes:  74 (Vote Underperform)
Total Votes:  116
MarketBeat's community ratings are surveys of what our community members think about Paladin Labs and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Paladin Labs (TSE:PLB) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Paladin Labs (TSE:PLB) Earnings History and Estimates Chart

Earnings by Quarter for Paladin Labs (TSE:PLB)

Paladin Labs (TSE PLB) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/14/2013Q3C$0.66C$0.61ViewListenView Earnings Details
8/14/2013Q2 2013C$0.48C$0.64ViewN/AView Earnings Details
5/9/2013Q1 2013C$0.47C$0.51ViewN/AView Earnings Details
2/28/2013Q4 2012C$0.48C$0.61ViewN/AView Earnings Details
11/13/2012Q3 2012C$0.49C$1.19ViewN/AView Earnings Details
8/2/2012Q2 2012C$0.47C$0.52ViewN/AView Earnings Details
5/3/2012Q1 2012C$0.30C$0.54ViewN/AView Earnings Details
2/16/2012Q4 2011C$0.41C$0.76ViewN/AView Earnings Details
11/3/2011Q3 2011C$0.36C$0.46ViewN/AView Earnings Details
8/11/2011Q2 2011C$0.36C$0.48ViewN/AView Earnings Details
5/25/2011Q1 2011C$0.40C$0.40ViewN/AView Earnings Details
2/17/2011Q4 2010C$0.27C$0.50ViewN/AView Earnings Details
11/4/2010Q3 2010C$0.22C$0.41ViewN/AView Earnings Details
8/5/2010Q2 2010C$0.15C$0.24ViewN/AView Earnings Details
5/6/2010Q1 2010C$0.12C$0.16ViewN/AView Earnings Details
2/25/2010Q4 2009C$0.13C$0.05ViewN/AView Earnings Details
11/11/2009Q3 2009C$0.13C$0.13ViewN/AView Earnings Details
8/11/2009Q2 2009C$0.15C$0.08ViewN/AView Earnings Details
5/7/2009Q1 2009C$0.16C$0.20ViewN/AView Earnings Details
2/26/2009Q4 2008C$0.17C$0.14ViewN/AView Earnings Details
11/6/2008Q3 2008C$0.10C$0.24ViewN/AView Earnings Details
8/7/2008Q2 2008C$0.10C$0.17ViewN/AView Earnings Details
5/15/2008Q1 2008C$0.08C$0.10ViewN/AView Earnings Details
2/28/2008Q4 2007C$0.03C$0.07ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Paladin Labs (TSE:PLB) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Paladin Labs (TSE:PLB)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Paladin Labs (TSE PLB)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Paladin Labs (TSE PLB) News Headlines

Source:

SEC Filings

Paladin Labs (TSE:PLB) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Paladin Labs (TSE PLB) Stock Chart for Tuesday, January, 16, 2018

Loading chart…

This page was last updated on 1/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.